You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2024

PTAB Cases from Mylan Pharmaceuticals Inc


✉ Email this page to a colleague

« Back to Dashboard


Patent Trial and Appeal Board Cases for Petitioner: Mylan Pharmaceuticals Inc

Patent Petitioner Status Filing Date Accorded Filing Date Patent Owner Trial Type Trial Number Decision Date Inventor Document Download
6,858,650 Mylan Pharmaceuticals Inc et al. ⤷  Sign Up 2016-01-28 01-28-2016 UCB Pharma GmbH Inter partes review ⤷  Sign Up 07-20-2016 Claus Meese ⤷  Sign Up
7,157,456 Mylan Pharmaceuticals Inc et al. ⤷  Sign Up 2016-10-07 10-07-2016 Straub et al Inter partes review ⤷  Sign Up ⤷  Sign Up
8,992,486 Mylan Pharmaceuticals Inc et al. ⤷  Sign Up 2018-09-10 09-10-2018 Inter partes review ⤷  Sign Up ⤷  Sign Up
9,526,844 Mylan Pharmaceuticals Inc et al. ⤷  Sign Up 2018-09-10 09-10-2018 Inter partes review ⤷  Sign Up 04-03-2019 ⤷  Sign Up
5,856,336 Mylan Pharmaceuticals Inc. ⤷  Sign Up 2015-04-18 04-18-2015 Nissan Chemical Industries, Ltd. Inter partes review ⤷  Sign Up 10-20-2015 YOSHIHIRO FUJIKAWA ⤷  Sign Up
5,922,695 Mylan Pharmaceuticals Inc. ⤷  Sign Up 2014-06-04 06-04-2014 Gilead Sciences, Inc. Inter partes review ⤷  Sign Up 12-09-2014 MURTY ARIMILLI ⤷  Sign Up
>Patent >Petitioner >Status >Filing Date >Accorded Filing Date >Patent Owner >Trial Type >Trial Number >Decision Date >Inventor >Document Download

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.